Scientists at Scripps Research recently launched a new clinical trial that will test if a repurposed GLP-1 drug, tirzepatide, can provide possible relief for long COVID symptoms.Monday on Midday Edition, we sit down with Dr. Eric Topol to hear more about the trial and the state of long COVID research and treatment today.Guest:Dr. Eric Topol, executive vice president, Scripps Research Translational InstituteResources: Long COVID Treatment Trial — Scripps Research